{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:01:27Z","timestamp":1760781687306},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ogc.2011.12.004","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T15:59:50Z","timestamp":1327852790000},"page":"1-16","source":"Crossref","is-referenced-by-count":11,"title":["Progesterone for Preterm Birth Prevention"],"prefix":"10.1016","volume":"39","author":[{"given":"Carla E.","family":"Ransom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy P.","family":"Murtha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ogc.2011.12.004_bib1","first-page":"1","article-title":"Infant mortality statistics from the 2005 period linked birth\/infant death data set","volume":"57","author":"Mathews","year":"2008","journal-title":"Natl Vital Stat Rep"},{"issue":"24","key":"10.1016\/j.ogc.2011.12.004_bib2","first-page":"1","article-title":"Births: final data for 2007","volume":"58","author":"Martin","year":"2010","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib3","first-page":"1","article-title":"Births: Preliminary data for 2009","volume":"59","author":"Hamilton","year":"2010","journal-title":"National Vital Statistics Report"},{"key":"10.1016\/j.ogc.2011.12.004_bib4","series-title":"Long-term outcome","author":"Koppe","year":"1998"},{"key":"10.1016\/j.ogc.2011.12.004_bib5","series-title":"Final natality data","year":"2008"},{"issue":"Suppl I","key":"10.1016\/j.ogc.2011.12.004_bib6","first-page":"5S","article-title":"Preterm birth: a puzzle worth solving","volume":"76","author":"Morrison","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ogc.2011.12.004_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.299.12.1429","article-title":"Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth","volume":"299","author":"Swamy","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2471\/BLT.08.062554","article-title":"The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity","volume":"88","author":"Beck","year":"2010","journal-title":"Bull World Health Organ"},{"issue":"20","key":"10.1016\/j.ogc.2011.12.004_bib9","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM199811123392004","article-title":"Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994","volume":"339","author":"Joseph","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2011.12.004_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2393-9-6","article-title":"Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial","volume":"9","author":"Dodd","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"issue":"Suppl 20","key":"10.1016\/j.ogc.2011.12.004_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1471-0528.2003.00021.x","article-title":"Classification and heterogeneity of preterm birth","volume":"110","author":"Moutquin","year":"2003","journal-title":"BJOG"},{"issue":"12","key":"10.1016\/j.ogc.2011.12.004_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/14767050600949829","article-title":"Mechanisms of progesterone action in inhibiting prematurity","volume":"19","author":"Sfakianaki","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.humrep.a136909","article-title":"Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study","volume":"4","author":"Hegele-Hartung","year":"1989","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib14","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.ajog.2008.06.085","article-title":"Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions","volume":"199","author":"Ruddock","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2011.12.004_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/aja.1000980206","article-title":"Progesterone block","volume":"98","author":"Csapo","year":"1956","journal-title":"Am J Anat"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/molehr\/7.6.581","article-title":"Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the \u2018functional progesterone withdrawal\u2019","volume":"7","author":"Allport","year":"2001","journal-title":"Mol Hum Reprod"},{"issue":"11","key":"10.1016\/j.ogc.2011.12.004_bib17","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/me.2006-0112","article-title":"Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression","volume":"20","author":"Hardy","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"16","key":"10.1016\/j.ogc.2011.12.004_bib18","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.1633616100","article-title":"A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition","volume":"100","author":"Condon","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1369\/jhc.5A6759.2006","article-title":"Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix","volume":"54","author":"Marx","year":"2006","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib20","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.ajog.2008.01.029","article-title":"Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?","volume":"198","author":"Xu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endo-128-1-371","article-title":"Immunochemical and immunohistochemical evidence of estrogen-mediated collagenolysis as a mechanism of cervical dilatation in the guinea pig at parturition","volume":"128","author":"Rajabi","year":"1991","journal-title":"Endocrinology"},{"issue":"Pt 1","key":"10.1016\/j.ogc.2011.12.004_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj3010183","article-title":"Suppression of interleukin 8 production by progesterone in rabbit uterine cervix","volume":"301","author":"Ito","year":"1994","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.07.016","article-title":"Intramuscular 17alpha-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells","volume":"203","author":"Foglia","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib24","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2007.01.007","article-title":"Progesterone protects fetal chorion and maternal decidua cells from calcium-induced death","volume":"196","author":"Murtha","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2011.12.004_bib25","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1210\/jc.2005-0210","article-title":"Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery","volume":"90","author":"Cakmak","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm0595-460","article-title":"A placental clock controlling the length of human pregnancy","volume":"1","author":"McLean","year":"1995","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.0.1240001","article-title":"Prostaglandins and mechanisms of preterm birth","volume":"124","author":"Challis","year":"2002","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00404-005-0728-0","article-title":"Regulation of progesterone production in human term trophoblasts in vitro by CRH, ACTH and cortisol (prednisolone)","volume":"272","author":"Jeschke","year":"2005","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm0596-556","article-title":"Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor","volume":"2","author":"Karalis","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.ogc.2011.12.004_bib30","first-page":"30","article-title":"Habitual abortion: a controlled study of progestational therapy","volume":"72","author":"Levine","year":"1964","journal-title":"West J Surg Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.ogc.2011.12.004_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ogc.2011.12.004_bib32","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ogc.2011.12.004_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib35","doi-asserted-by":"crossref","first-page":"54.e1","DOI":"10.1016\/j.ajog.2010.08.022","article-title":"Women with preterm premature rupture of the membranes do not benefit from weekly progesterone","volume":"204","author":"Briery","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2011.12.004_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SMJ.0b013e3181afee12","article-title":"Progesterone does not prevent preterm births in women with twins","volume":"102","author":"Briery","year":"2009","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib37","first-page":"692","article-title":"Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy","volume":"56","author":"Hartikainen-Sorri","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"9680","key":"10.1016\/j.ogc.2011.12.004_bib38","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"10.1016\/j.ogc.2011.12.004_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib41","doi-asserted-by":"crossref","first-page":"248.e1","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2011.12.004_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery","volume":"334","author":"Iams","year":"1996","journal-title":"N Engl J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.ogc.2011.12.004_bib43","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9378(99)70111-0","article-title":"The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome","volume":"181","author":"Mercer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.7338","article-title":"Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial","volume":"34","author":"O'Brien","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib48","doi-asserted-by":"crossref","first-page":"375.e1","DOI":"10.1016\/j.ajog.2009.08.015","article-title":"Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length","volume":"201","author":"Owen","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1515\/JPM.2009.083","article-title":"A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix","volume":"37","author":"Keeler","year":"2009","journal-title":"J Perinat Med"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib50","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2010.02.019","article-title":"17-Alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length","volume":"202","author":"Berghella","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ogc.2011.12.004_bib51","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/14767051003702786","article-title":"Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-alpha hydroxyprogesterone caproate","volume":"23","author":"Durnwald","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib52","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/AOG.0b013e31818b1ff6","article-title":"Use of progesterone to reduce preterm birth","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.06.020","article-title":"Impact of prior gestational age at preterm delivery on effectiveness of 17-alpha-hydroxyprogesterone caproate in practice","volume":"203","author":"Gonzalez-Quintero","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2008.08.029","article-title":"Oral micronized progesterone for prevention of preterm birth","volume":"104","author":"Rai","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0031-1274509","article-title":"A randomized trial of micronized progesterone for the prevention of recurrent preterm birth","volume":"28","author":"Glover","year":"2011","journal-title":"Am J Perinatol"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","article-title":"Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India","volume":"29","author":"Majhi","year":"2009","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ogc.2011.12.004_bib58","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/humrep\/12.5.1073","article-title":"Targeted drug delivery in gynaecology: the first uterine pass effect","volume":"12","author":"Bulletti","year":"1997","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0029-7844(99)00542-6","article-title":"Direct transport of progesterone from vagina to uterus","volume":"95","author":"Cicinelli","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.004_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0015-0282(16)58226-0","article-title":"Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women","volume":"65","author":"Cicinelli","year":"1996","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ogc.2011.12.004_bib62","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1081\/DDC-200040251","article-title":"Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel","volume":"30","author":"Mahaguna","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2011.12.004_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/humrep\/15.suppl_1.166","article-title":"Vaginal delivery of progesterone in donor oocyte therapy","volume":"15","author":"Toner","year":"2000","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib64","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/AOG.0b013e31821c6fb1","article-title":"Deus ex Makena?","volume":"117","author":"Silver","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14767050601152845","article-title":"Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery","volume":"20","author":"Gonzalez-Quintero","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.07.013","article-title":"Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?","volume":"197","author":"How","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2011.12.004_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.01.002","article-title":"Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Rebarber","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib68","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ajog.2006.06.034","article-title":"Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey","volume":"195","author":"Ness","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2011.12.004_bib69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000150560.24297.4f","article-title":"Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States","volume":"105","author":"Petrini","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2011.12.004_bib70","first-page":"775","article-title":"Teratogenicity of progestogens given during the first trimester of pregnancy","volume":"65","author":"Katz","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib71","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)48490-6","article-title":"Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936\u20131974","volume":"43","author":"Resseguie","year":"1985","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ogc.2011.12.004_bib72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/tera.1420380206","article-title":"Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects","volume":"38","author":"Yovich","year":"1988","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0b013e31817d0262","article-title":"Progesterone for the prevention of preterm birth: a systematic review","volume":"112","author":"Dodd","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2011.12.004_bib74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1043-2760(03)00003-1","article-title":"Progesterone in gestational diabetes mellitus: guilty or not guilty?","volume":"14","author":"Branisteanu","year":"2003","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ogc.2011.12.004_bib75","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/dc07-0564","article-title":"Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery","volume":"30","author":"Rebarber","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ogc.2011.12.004_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/AOG.0b013e3181a9454b","article-title":"Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy","volume":"114","author":"Waters","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.036","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies","volume":"201","author":"Gyamfi","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2011.12.004_bib78","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854511001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854511001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:51:41Z","timestamp":1543265501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854511001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0889854511001276"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2011.12.004","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}